Abstract

BackgroundWe recently reported that estrogen receptor α (ERα), even in absence of estrogen (E2), plays a critical role in lactotroph homeostasis. The anti-estrogen ICI 182780 (ICI), but not tamoxifen or raloxifene, rapidly promoted the degradation of ERα, and inhibited cell proliferation. However, all three ER antagonists suppressed PRL release, suggesting that receptor occupation is sufficient to inhibit prl gene expression whereas receptor degradation is required to suppress lactotroph proliferation. In this study our objective was to determine whether ERα degradation versus occupation, differentially modulates the biological outcome of anti-estrogens.Principal FindingsUsing the rat lactotroph cell line, GH3 cells, we report that ICI induced proteosome mediated degradation of ERα. In contrast, an ERα specific antagonist, MPP, that does not promote degradation of ERα, did not inhibit cell proliferation. Further, ICI, but not MPP, abolished anchorage independent growth of GH3 cells. Yet, both ICI and MPP were equally effective in suppressing prl expression and release, as well as ERE-mediated transcriptional activity.ConclusionTaken together, our results demonstrate that in lactotrophs, ERα degradation results in decreased cell proliferation, whereas ERα occupation by an antagonist that does not promote degradation of ERα is sufficient to inhibit prl expression.

Highlights

  • Drugs that block estrogen receptor (ER) activation/function are categorized as anti-estrogens

  • We report that in GH3 cells estrogen receptor a (ERa) degradation sets in motion a signal cascade that culminates in the inhibition of cell proliferation, while occupation of ERa by an antagonist is sufficient to inhibit prl expression and release

  • We have recently reported that anti-estrogens had differential effects on lactotroph proliferation[20]

Read more

Summary

Introduction

Drugs that block estrogen receptor (ER) activation/function are categorized as anti-estrogens. Several mechanisms have been proposed to characterize ICImediated ER antagonism These include competition with ligand binding to the ER, inhibition of transactivation domains (AF-1 and AF-2), prevention of ER dimerization and nuclear localization [2,3], and downregulation of ER [4]. Both ERaand ERb-mediated transcription is inhibited by ICI, indicating that both receptor subtypes are targets of ICI [5,6]. In this study our objective was to determine whether ERa degradation versus occupation, differentially modulates the biological outcome of anti-estrogens

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call